Ew Healthcare Partners Fund 2, L.P.'s Form 4 filing
TELA Bio, Inc. (TELA) · filed Dec 8, 2021
- Accession no.
- 0000899243-21-047397
- Filed
- Dec 8, 2021, 6:47 PM ET
- Trade date
- Dec 6-8, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market purchases total $278.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ew Healthcare Partners Fund 2, L.P.CIK 0001746777 | Other: See footnote 2 |
| Ew Healthcare Partners Fund 2-A, L.P.CIK 0001746779 | Other: See footnote 2 |
| EW Healthcare Partners Fund 2 GP, L.P.CIK 0001793943 | 10% Owner |
| EW Healthcare Partners Fund 2-UGP, LLCCIK 0001793948 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 6, 2021 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +10,000 | $12.39 | +$123,900 | 1,861,990 | Indirect | |
| Dec 7, 2021 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +11,148 | $12.32 | +$137,343.36 | 1,873,138 | Indirect | |
| Dec 8, 2021 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +1,425 | $12.39 | +$17,655.75 | 1,874,563 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.